![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh-vvlLIqfFotf3UNiFgx-ciK0-FVzgg-jfDazG5InLty1g9tGp8k4zIje_gXdawkZ_zSsOHZUWMAb-DtEtslbLcZJ-NNDVlCP2HyNq0ukQHQFMr6IclgbIRdH9msHbeZ0M-oLj0v5lzQ/s200/braveheart.gif)
"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.
Thursday 10 July 2008
Braveheart pays for options on Aberdeen research results
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh-vvlLIqfFotf3UNiFgx-ciK0-FVzgg-jfDazG5InLty1g9tGp8k4zIje_gXdawkZ_zSsOHZUWMAb-DtEtslbLcZJ-NNDVlCP2HyNq0ukQHQFMr6IclgbIRdH9msHbeZ0M-oLj0v5lzQ/s200/braveheart.gif)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment